This dynamic initiative will combine evidence- and case-based discussions to promote translation of educational concepts to practice, amplify retention of learning, and provide real-world tools to improve patient care. The initiative will include: * Series of five (5), 1-hour, Live Hospital Rounds Presentations, to be held at Academic Centers with Genetic Medicine Programs from August 2019 through March 2020. * Interactive, On-Demand, Archive of the Live Hospital Rounds Presentation, to endure online for 1 year.

1. Recognize the natural history and clinical manifestations of FD to facilitate timely recognition and differential diagnosis.
2. Assess the clinical impact of FD in heterozygous female patients, as well as unique considerations for their diagnosis & management.
3. Describe recently-identified genotype-phenotype correlations in FD, and how different mutations may affect disease progression, severity, and/or response to treatment.
4. Develop patient-specific FD management plans for pediatric and adult populations that consider published recommendations, individual clinical factors, patient goals, & novel FD therapies.